|Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors|
A Egli, L Infanti, A Dumoulin, A Buser, J Samaridis, C Stebler, R Gosert, ...
The Journal of infectious diseases 199 (6), 837-846, 2009
|Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology|
R Gosert, CH Rinaldo, GA Funk, A Egli, E Ramos, CB Drachenberg, ...
The Journal of experimental medicine 205 (4), 841-852, 2008
|Polyomavirus BK‐specific cellular immune response to VP1 and large T‐antigen in kidney transplant recipients|
S Binggeli, A Egli, S Schaub, I Binet, M Mayr, J Steiger, HH Hirsch
American Journal of Transplantation 7 (5), 1131-1139, 2007
|Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs|
A Egli, S Köhli, M Dickenmann, HH Hirsch
Transplantation 88 (10), 1161-1168, 2009
|The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections|
A Egli, DM Santer, D O’Shea, DL Tyrrell, M Houghton
Emerging microbes & infections 3 (1), 1-12, 2014
|State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician|
A Egli, A Humar, D Kumar
Clinical infectious diseases 55 (12), 1678-1689, 2012
|Cytomegalovirus and polyomavirus BK posttransplant|
A Egli, S Binggeli, S Bodaghi, A Dumoulin, GA Funk, N Khanna, ...
Nephrology Dialysis Transplantation 22 (suppl_8), viii72-viii82, 2007
|Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients|
A Egli, I Binet, S Binggeli, C Jäger, A Dumoulin, S Schaub, J Steiger, ...
Journal of translational medicine 6 (1), 1-12, 2008
|Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study|
J Coussement, ...
Reviews of Infectious Diseases 63 (3), 338-345, 2016
|A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study|
TM Walker, M Merker, AM Knoblauch, P Helbling, OD Schoch, ...
The Lancet Infectious Diseases 18 (4), 431-440, 2018
|Interferon lambda: modulating immunity in infectious diseases|
M Syedbasha, A Egli
Frontiers in immunology 8, 119, 2017
|Gut microbiota modulate T cell trafficking into human colorectal cancer|
E Cremonesi, V Governa, JFG Garzon, V Mele, F Amicarella, MG Muraro, ...
Gut 67 (11), 1984-1994, 2018
|IL-28B is a key regulator of B-and T-cell vaccine responses against influenza|
A Egli, DM Santer, D O'Shea, K Barakat, M Syedbasha, M Vollmer, ...
PLoS Pathog 10 (12), e1004556, 2014
|Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells|
MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ...
The Journal of clinical investigation 128 (11), 4912-4923, 2018
|Randomized controlled trial of high‐dose intradermal versus standard‐dose intramuscular influenza vaccine in organ transplant recipients|
A Baluch, A Humar, D Eurich, A Egli, A Liacini, K Hoschler, P Campbell, ...
American Journal of Transplantation 13 (4), 1026-1033, 2013
|Immunomodulatory function of interleukin 28B during primary infection with cytomegalovirus|
A Egli, A Levin, DM Santer, M Joyce, D O'Shea, BS Thomas, LF Lisboa, ...
The Journal of infectious diseases 210 (5), 717-727, 2014
|Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events|
H Läubli, C Balmelli, L Kaufmann, M Stanczak, M Syedbasha, D Vogt, ...
Journal for immunotherapy of cancer 6 (1), 1-10, 2018
|Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation|
O Manuel, A Wójtowicz, S Bibert, NJ Mueller, C Van Delden, HH Hirsch, ...
The Journal of infectious diseases 211 (6), 906-914, 2015
|Outbreak investigation for toxigenic Corynebacterium diphtheriae wound infections in refugees from Northeast Africa and Syria in Switzerland and Germany by whole genome sequencing|
DM Meinel, R Kuehl, R Zbinden, V Boskova, C Garzoni, D Fadini, ...
Clinical Microbiology and Infection 22 (12), 1003. e1-1003. e8, 2016
|Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial|
M Osthoff, N Gürtler, S Bassetti, G Balestra, S Marsch, H Pargger, ...
Clinical Microbiology and Infection 23 (2), 78-85, 2017